Darya Chudova - Mar 1, 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Technology Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Darya Chudova
Stock symbol
GH
Transactions as of
Mar 1, 2024
Transactions value $
-$2,466
Form type
4
Date filed
3/4/2024, 06:34 PM
Previous filing
Jan 16, 2024
Next filing
Apr 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +316 +0.9% $0.00 35.6K Mar 1, 2024 Direct
transaction GH Common Stock Tax liability -$2.47K -130 -0.36% $18.97 35.5K Mar 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -316 -14.3% $0.00 1.89K Mar 1, 2024 Common Stock 316 $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 The restricted stock unit award was granted on November 2, 2021, of which 3,157 shares are outstanding on May 3, 2023, when elected as an executive officer. These shares vest in equal quarterly installments on the anniversary of 9/1/2022, and fully vested on 9/1/2025.
F3 Not applicable for Restricted Stock Units.